HEAD AND NECK NEOPLASMS
Clinical trials for HEAD AND NECK NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK NEOPLASMS trials appear
Sign up with your email to follow new studies for HEAD AND NECK NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo shows promise for tough head and neck cancers
Disease control CompletedThis phase 2 study tested two drugs—durvalumab and cetuximab—together in 35 people with head and neck cancer that had come back or spread and was no longer responding to standard treatments. The goal was to see if the combination could shrink tumors. The study is complete, and re…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE2 • Sponsor: Trisha Wise-Draper • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control CompletedThis study tested a combination of two drugs, atezolizumab and bevacizumab, in 33 adults with advanced head and neck cancer that had worsened after chemotherapy. The goal was to see if the combo could shrink tumors or slow disease progression. Results may help guide future treatm…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immunotherapy combo shows promise in head and neck cancer trial
Disease control CompletedThis large Phase 3 trial tested whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard chemoradiation helps people with locally advanced head and neck cancer live longer without the disease getting worse. Over 800 participants received either pembrolizumab plu…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug combo shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had returned or spread. The goal was to see if the combination could shrink tumors or slow the disease. Participants were grouped based on whether they …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New oral drug takes on standard chemo for head and neck cancer
Disease control CompletedThis Phase 3 trial tested whether the oral drug afatinib works better than the standard injected drug methotrexate for people with advanced head and neck cancer that has worsened after platinum chemotherapy. The study enrolled 340 patients and measured how long they lived without…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Neck surgery before Chemo-Radiation may reduce side effects in head and neck cancer patients
Disease control CompletedThis study looked at 65 people with advanced head and neck cancer that had spread to lymph nodes. It compared two approaches: having surgery to remove affected lymph nodes before chemo-radiation, versus chemo-radiation alone. The goal was to see if upfront surgery could reduce tr…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Smarter radiation dosing aims to cut side effects for head and neck cancer patients
Disease control CompletedThis study tested a new way of giving radiation to people with head and neck cancer. The goal was to lower the radiation dose to healthy neck areas to reduce side effects like trouble eating, while still keeping the cancer from coming back. About 300 patients took part, and the r…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Pre-Treatment workouts may boost strength in head and neck cancer patients
Symptom relief CompletedThis study tested whether a short exercise program before chemoradiotherapy helps head and neck cancer patients maintain physical function. 47 adults with head and neck cancer were randomly assigned to either an exercise prehabilitation group or usual care. The exercise program l…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Associacao de Investigacao de Cuidados de Suporte em Oncologia • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Ozone treatment eases painful mouth sores in cancer patients
Symptom relief CompletedThis study tested whether ozone therapy can help treat oral mucositis—painful mouth sores—in 38 patients receiving radiation and chemotherapy for head and neck cancer. Patients received in-office ozone gas treatment plus at-home ozonated oil products. The researchers measured cha…
Matched conditions: HEAD AND NECK NEOPLASMS
Sponsor: Andrea Scribante • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Acupuncture needles may boost blood counts and ease fatigue in cancer patients
Symptom relief CompletedThis study tested whether manual acupuncture, compared to a sham (fake) version, could improve white blood cell counts and reduce fatigue in 34 head and neck cancer patients undergoing chemoradiation. Participants received 21 sessions over seven weeks at specific body points. The…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Laser or ozone: which eases cancer mouth sores best?
Symptom relief CompletedThis study tested two treatments—laser therapy and ozone gas—to relieve painful mouth sores caused by cancer treatment. Forty adults with head and neck or blood cancers took part. Each received one treatment daily for five days. The goal was to see which therapy better reduced so…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: University of Pavia • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Nutrition boost may ease radiation side effects in head and neck cancer
Symptom relief CompletedThis completed study tested whether active nutritional support with high-protein drinks can reduce the occurrence of painful mouth sores (mucositis) and improve quality of life in head and neck cancer patients undergoing radiotherapy. The study enrolled 47 newly diagnosed adults …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 26, 2026 15:27 UTC
-
X-Ray study tracks head movement during cancer radiation
Knowledge-focused CompletedThis study collected X-ray images from 32 head and neck cancer patients during their radiation therapy sessions. The goal was to measure how much the head moves or changes shape between treatments. Researchers also used the images to create realistic artificial X-rays for future …
Matched conditions: HEAD AND NECK NEOPLASMS
Sponsor: University of Sydney • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New imaging technique could help doctors predict cancer treatment response
Knowledge-focused CompletedThis study tested whether a PET scan using a tracer called FMISO can measure oxygen levels (hypoxia) in head and neck cancers. Sixteen patients received the scan before starting radiotherapy. The goal was to see if the amount of hypoxia seen on the scan could predict how well the…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
3D nerve mapping could make Kids' head and neck surgery safer
Knowledge-focused CompletedThis completed study tested a new 3D MRI technique to map cranial nerves in 7 children aged 1 to 5 with head and neck tumors or birth defects. The goal was to create detailed models that help surgeons avoid damaging important nerves during operations. The research focused on deve…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC